Novavax

The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter clinical trial requirements for healthy adults. What Happened: The FDA will now require new...

The President Donald Trump administration’s request for Novavax Inc. (NASDAQ:NVAX) to conduct new clinical trials for its COVID-19 vaccine. What Happened: Novavax announced Monday that the Food and Drug Administration requested a new clinical trial before granting full approval for its...

On Wednesday, major U.S. indices saw gains, with the Dow Jones Industrial Average climbing nearly 0.8% to 43,077.70, while the S&P 500 increased 0.5% to 5,842.47. The Nasdaq finished the day up almost 0.3% at 18,367.08. These are the top stocks that gained the attention of retail traders and...

Novavax Inc. (NASDAQ:NVAX) shares surged after the company announced its plans to deliver a regulator-recommended vaccine against a strain of Covid-19 by September. What Happened: The Maryland-based biotechnology company’s shares were trading higher by 21.60% to $25.50 in premarket trading on...

On Tuesday, the U.S. indices exhibited a varied performance, as the S&P 500 rose by nearly 0.2% to reach 5,078.18, while the Dow Jones Industrial Average dipped by 0.25% to settle at 38,972.41. Concurrently, the Nasdaq experienced a nearly 0.4% increase, reaching 16,035.30. These are the top...

U.S. stocks experienced a downturn, with significant losses noted toward the end of trading. The S&P 500 fell approximately 1.4%, echoing the performance of the Dow and the NASDAQ, which declined by 1.3% and 1.9% respectively. These are the top stocks that gained the attention of retail...

U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday. The tech-heavy index closed at 13,917.89 for the day. The Dow Jones Industrial Average also reflected an upward trend, increasing by 0.25%...

U.S. stocks ended in red at the end of the trading day. The Dow Jones experienced a dip, falling by nearly 200 points or 0.56% to settle at 34,641.97. In contrast, the NASDAQ exhibited a slight decline, falling by 0.08% to 14,020.95. The S&P 500 also witnessed a decline, dropping by 0.42% to 4,...

In today’s market, both the S&P 500 and Nasdaq indices experienced fluctuations. On Tuesday, the S&P 500 closed 0.28% lower at 4,387.55, while Nasdaq ended the day higher by 0.06% at 13,505.87. The Dow Jones Industrial Average was down 0.51% at 34,288.83. These are the top stocks that...

Moderna Inc. (NASDAQ: MRNA) and Novavax Inc. (NASDAQ: NVAX) were trading down over 2% and 4%, respectively in the premarket Friday despite both stocks showing signs a bounce could be in the cards. The weak price action in the pharmaceutical giants is likely due to very bearish action in the general...

This weekend's Barron's cover story offers a look at the 100 must sustainable companies. Other featured articles discuss the changing vaccine industry, the history of electric vehicles and consolidation in the defense sector. Also, the prospects for a medical-diagnostics company, a high-...

The last day of a volatile and heavily traded stock market week opens this morning with investors apparently feeling uneasy given the state of certain speculative trades that have been in the spotlight for days. At the moment it seems like there is a little bit of turnover in the market, with...

Benzinga has examined the prospects for many investor favorite stocks over the past week. This past week's bullish calls included the iPhone maker and other tech leaders. The leading EV maker and a top biotech were among the bearish calls. The big three U.S. stock indexes ended the past week...

Benzinga has examined the prospects for many investor favorite stocks over the past week. This week's bullish calls included pharmaceutical and ride-share leaders. The e-commerce colossus and the iPhone maker were among the week's bearish calls. A July employment report that was better...